These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 2838941)
1. Decreased rate of growth of hepatocellular carcinoma recurrence after liver transplantation in patients maintained on cyclosporine immunosuppression. O'Grady JG; Johnson PJ; Zaman S; Calne RY; Williams R Transplant Proc; 1988 Jun; 20(3 Suppl 3):394-6. PubMed ID: 2838941 [No Abstract] [Full Text] [Related]
2. Tumor size remains key for prediction of hepatocellular carcinoma recurrence after liver transplantation. Earl TM; Chapman WC Ann Surg Oncol; 2011 May; 18(5):1217-8. PubMed ID: 21327456 [No Abstract] [Full Text] [Related]
8. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence. Vivarelli M; Cucchetti A; La Barba G; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815 [TBL] [Abstract][Full Text] [Related]
10. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression. Vivarelli M; Cucchetti A; Piscaglia F; La Barba G; Bolondi L; Cavallari A; Pinna AD Liver Transpl; 2005 May; 11(5):497-503. PubMed ID: 15838913 [TBL] [Abstract][Full Text] [Related]
12. Analysis of risk factors for recurrence of hepatocellular carcinoma after orthotopic liver transplantation. Lohmann R; Bechstein WO; Langrehr JM; Knoop M; Lobeck H; Keck H; Lemmems HP; Blumhardt G; Neuhaus P Transplant Proc; 1995 Feb; 27(1):1245-6. PubMed ID: 7533376 [No Abstract] [Full Text] [Related]
13. How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated? Schwartz M; Roayaie S; Llovet J J Hepatol; 2005 Oct; 43(4):584-9. PubMed ID: 16120468 [No Abstract] [Full Text] [Related]
14. Tumor surveillance-what can and should be done? Screening for recurrence of hepatocellular carcinoma after liver transplantation. Roberts JP Liver Transpl; 2005 Nov; (11 Suppl 2):S45-6. PubMed ID: 16237702 [TBL] [Abstract][Full Text] [Related]
15. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma. Reddy MS; Manas DM Transplantation; 2007 Feb; 83(3):367-8. PubMed ID: 17297420 [No Abstract] [Full Text] [Related]
16. Down-staging of hepatocellular carcinoma before liver transplantation: should we change our clinical practice? Ravaioli M; Grazi GL; Cescon M; Ercolani G; Pinna AD; Piscaglia F; Trevisani F Ann Surg; 2009 Aug; 250(2):348; author reply 348-9. PubMed ID: 19638902 [No Abstract] [Full Text] [Related]
17. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation. Heckman JT; Devera MB; Marsh JW; Fontes P; Amesur NB; Holloway SE; Nalesnik M; Geller DA; Steel JL; Gamblin TC Ann Surg Oncol; 2008 Nov; 15(11):3169-77. PubMed ID: 18696158 [TBL] [Abstract][Full Text] [Related]
18. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate. Stockland AH; Walser EM; Paz-Fumagalli R; McKinney JM; May GR Cardiovasc Intervent Radiol; 2007; 30(5):888-93. PubMed ID: 17619218 [TBL] [Abstract][Full Text] [Related]